Mark Bates
Dublin, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Lipid metabolism in γδ T-cell activation: Implications for immunotherapy in ovarian cancer.
Journal: Translational oncology
Published: March 09, 2026
FOXP3 is a favourable prognostic indicator in oesophageal adenocarcinoma.
Journal: Pathology, research and practice
Published: January 26, 2025
Biomarkers in high grade serous ovarian cancer.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: January 28, 2024
P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancer.
Journal: Pathology, research and practice
Published: November 21, 2023
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1.
Journal: Cancers
Published: May 19, 2023
Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression.
Journal: Scientific reports
Published: March 15, 2023
Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in patients who have received neoadjuvant chemotherapy.
Journal: Frontiers in cell and developmental biology
Published: January 25, 2023
Circulating tumour cells: The Good, the Bad and the Ugly.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: July 06, 2022
Ex vivo expansion of circulating tumour cells (CTCs).
Journal: Scientific reports
Published: May 19, 2022
The induction of a mesenchymal phenotype by platelet cloaking of cancer cells is a universal phenomenon.
Journal: Translational oncology
Published: September 15, 2021
Prognostic features of the tumour microenvironment in oesophageal adenocarcinoma.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: February 08, 2021
Last Updated: 09/26/2026